Akebia Therapeutics (AKBA) Cash & Equivalents Growth (1y) (2014 - 2026)
Akebia Therapeutics (AKBA) Cash & Equivalents Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 120.45% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 12.78% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | -32.64% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | -57.43% |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 37.30% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -12.11% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -12.07% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | -46.88% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -18.80% |
| 10 | Akebia Therapeutics | 235.00 Mn | 72.40 Mn | 41.25 Mn | 43.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.39% |
| Dec 31, 2025 | 256.36% |
| Sep 30, 2025 | 389.14% |
| Jun 30, 2025 | 247.62% |
| Mar 31, 2025 | 170.25% |
| Dec 31, 2024 | 20.84% |
| Sep 30, 2024 | -26.89% |
| Jun 30, 2024 | -26.31% |
| Mar 31, 2024 | -26.38% |
| Dec 31, 2023 | -52.55% |
| Sep 30, 2023 | -67.87% |
| Jun 30, 2023 | -62.75% |
| Mar 31, 2023 | -67.35% |
| Dec 31, 2022 | -39.61% |
| Sep 30, 2022 | -30.12% |
| Jun 30, 2022 | -41.74% |
| Mar 31, 2022 | -30.94% |
| Dec 31, 2021 | -34.50% |
| Sep 30, 2021 | 22.40% |
| Jun 30, 2021 | 0.65% |